To read the interview please follow this link to the official ASX release: An Open Briefing interview with MD Andrew McLellan - January 2022
Previous Post
Bluechiip signs License and Development Agreement with US-based Fujifilm Irvine Scientific
Next Post
Quarterly Activities/Appendix 4C Cash Flow Report